Once considered the effects of unequal, or evolving standards of care (environmental factors), and of certain DMD mutations (“cis-acting” genetic modifiers), the answer to the question of phenotype variability in dystrophin-null DMD patients lies in their genetic background. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.